Stock AVBP ARRIVENT BIOPHARMA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders ArriVent BioPharma, Inc.

Equities

AVBP

US04272N1028

Market Closed - Nasdaq
Other stock markets
 21:00:00 31/05/2024 BST 		5-day change 1st Jan Change
19.41 USD -0.26% Intraday chart for ArriVent BioPharma, Inc. +0.88% -.--%
05-16 ArriVent BioPharma, Inc. Appoints John Hohneker as Board of Directors CI
05-08 ArriVent BioPharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Insiders

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
ArriVent BioPharma, Inc. Appoints John Hohneker as Board of Directors
CI
ArriVent BioPharma, Inc. Appoints Kristine Peterson to Its Board of Directors
CI
Arrivent Biopharma Insider Bought Shares Worth $7,999,992, According to a Recent SEC Filing
MT
Arrivent Biopharma Insider Bought Shares Worth $7,999,992, According to a Recent SEC Filing
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AVBP Stock
  4. News ArriVent BioPharma, Inc.
  5. Insiders
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW